iHuman (IH) Cash & Equivalents (2019 - 2025)

iHuman (IH) has 7 years of Cash & Equivalents data on file, last reported at $162.3 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $162.3 million, up 3.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $162.3 million (up 3.79% YoY), and the FY2025 annual result was $164.6 million, up 6.96% from the prior year.
• Cash & Equivalents eased to $162.3 million in Q4 2025 per IH's latest filing, from $72.5 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $84.5 billion in Q2 2025 and troughed at $113113.8 in Q1 2022.
• A 5-year average of $11.3 billion and a median of $136.0 million in 2021 frame the typical range for Cash & Equivalents.
• On a YoY basis, Cash & Equivalents climbed as much as 67030.23% in 2025 and fell as far as 99.88% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $133.8 million in 2021, then grew by 10.35% to $147.6 million in 2022, then gained by 14.19% to $168.6 million in 2023, then fell by 7.24% to $156.4 million in 2024, then advanced by 3.79% to $162.3 million in 2025.
• Business Quant data shows IH's Cash & Equivalents at $162.3 million in Q4 2025, $72.5 billion in Q3 2025, and $84.5 billion in Q2 2025.